
Cidara Therapeutics CDTX
Cidara Therapeutics EV | CDTX
EV Jährlich Cidara Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.99 M | 41.7 M | 149 M | 80.3 M | 93.2 M | 80.4 M | 17.1 M | 89.7 M | 71.8 M | 59.2 M | -19.5 M | 1.41 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 149 M | -19.5 M | 56.2 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ADC Therapeutics SA
ADCT
|
386 M | $ 1.31 | 6.5 % | $ 166 M | ||
|
ADMA Biologics
ADMA
|
3.84 B | $ 9.7 | 3.21 % | $ 2.31 B | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
2.7 B | $ 27.89 | 0.3 % | $ 4.23 B | ||
|
Arcturus Therapeutics Holdings
ARCT
|
43.4 M | $ 13.3 | 1.06 % | $ 364 M | ||
|
AbbVie
ABBV
|
394 B | $ 265.08 | 0.02 % | $ 469 B | ||
|
Axsome Therapeutics
AXSM
|
8.95 B | $ 193.45 | 0.24 % | $ 9.62 B | ||
|
Aytu BioScience
AYTU
|
1.16 M | $ 2.28 | 2.24 % | $ 28.1 M | ||
|
Adagene
ADAG
|
176 M | $ 2.97 | 0.62 % | $ 175 M | ||
|
Abeona Therapeutics
ABEO
|
234 M | $ 5.53 | 2.65 % | $ 293 M | ||
|
Adial Pharmaceuticals
ADIL
|
-3.17 M | $ 4.04 | 0.24 % | $ 2.7 M | ||
|
Evelo Biosciences
EVLO
|
48.5 M | - | -14.46 % | $ 27.9 M | ||
|
BioMarin Pharmaceutical
BMRN
|
11.9 B | $ 62.21 | 0.06 % | $ 11.9 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
847 M | $ 4.85 | 0.2 % | $ 929 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-721 K | $ 2.16 | 0.45 % | $ 3.56 M | ||
|
Achieve Life Sciences
ACHV
|
126 M | $ 7.83 | 0.87 % | $ 341 M | ||
|
Catalyst Biosciences
CBIO
|
986 M | $ 14.19 | 1.17 % | $ 1.27 B | ||
|
Amryt Pharma plc
AMYT
|
2.89 B | - | - | $ 621 M | ||
|
C4 Therapeutics
CCCC
|
262 M | $ 3.08 | 0.3 % | $ 255 M | ||
|
Codexis
CDXS
|
157 M | $ 1.38 | 0.72 % | $ 120 M | ||
|
Allakos
ALLK
|
31 K | - | - | $ 28.6 M | ||
|
Cerus Corporation
CERS
|
632 M | $ 2.6 | 4.3 % | $ 496 M | ||
|
Coherus BioSciences
CHRS
|
335 M | $ 1.26 | 1.48 % | $ 148 M | ||
|
Celldex Therapeutics
CLDX
|
2.07 B | $ 31.12 | 0.28 % | $ 2.07 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
3.75 M | $ 4.04 | 4.94 % | $ 49.3 M | ||
|
AbCellera Biologics
ABCL
|
1.22 B | $ 12.31 | 0.12 % | $ 3.68 B | ||
|
Aclaris Therapeutics
ACRS
|
422 M | $ 5.26 | 2.69 % | $ 645 M | ||
|
Фармсинтез
LIFE
|
59.3 B | - | - | - | ||
|
Clovis Oncology
CLVS
|
870 M | - | -7.23 % | $ 13 M | ||
|
Cocrystal Pharma
COCP
|
7.76 M | $ 1.19 | 1.26 % | $ 13.4 M | ||
|
Collegium Pharmaceutical
COLL
|
2.52 B | $ 22.45 | 1.05 % | $ 711 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
3.82 B | $ 112.94 | 3.29 % | $ 11.7 B | ||
|
Crinetics Pharmaceuticals
CRNX
|
4.14 B | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
119 M | $ 7.74 | 0.19 % | $ 103 M | ||
|
Cardiff Oncology
CRDF
|
115 M | $ 1.31 | 0.74 % | $ 87.6 M | ||
|
Curis
CRIS
|
18.9 M | $ 0.95 | 0.98 % | $ 12.5 M | ||
|
CorMedix
CRMD
|
276 M | $ 7.69 | 0.06 % | $ 554 K | ||
|
CRISPR Therapeutics AG
CRSP
|
4.38 B | $ 55.76 | 1.2 % | $ 5.01 B | ||
|
Corvus Pharmaceuticals
CRVS
|
324 M | $ 12.54 | 8.21 % | $ 990 M | ||
|
Concert Pharmaceuticals
CNCE
|
15.7 M | - | - | $ 401 M | ||
|
Cue Biopharma
CUE
|
18 M | $ 31.71 | 2.62 % | $ 3 B | ||
|
CEL-SCI Corporation
CVM
|
21.1 M | $ 1.68 | 0.59 % | $ 13.5 M | ||
|
Cytokinetics, Incorporated
CYTK
|
1.97 B | $ 65.81 | 0.04 % | $ 7.9 M | ||
|
Axon Enterprise
AXON
|
33.2 B | $ 450.61 | 1.61 % | $ 35.2 B | ||
|
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | ||
|
DiaMedica Therapeutics
DMAC
|
296 M | $ 7.56 | 7.16 % | $ 355 M | ||
|
Denali Therapeutics
DNLI
|
2.34 B | $ 20.46 | 5.52 % | $ 3.53 B | ||
|
Precision BioSciences
DTIL
|
16 M | $ 6.36 | 10.62 % | $ 81.6 M | ||
|
Dyadic International
DYAI
|
35.6 M | $ 0.41 | 3.72 % | $ 14.8 M | ||
|
Editas Medicine
EDIT
|
218 M | $ 2.69 | 0.17 % | $ 239 M | ||
|
Edesa Biotech
EDSA
|
497 K | $ 3.97 | 1.46 % | $ 22.5 M |